Format

Send to

Choose Destination
J Neural Transm (Vienna). 2007 Mar;114(3):327-9. Epub 2006 Jul 25.

Pathogenic Lrrk2 substitutions and Amyotrophic lateral sclerosis.

Author information

1
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.

Abstract

Pathogenic Lrrk2 Y1699C substitution observed in a large German-Canadian kindred presents a neurodegenerative disorder that is reminiscent of amyotrophic lateral sclerosis and Parkinsonism-Dementia Complex. We screened 54 patients with ALS for seven known Lrrk2 pathogenic substitutions in the Roc, COR and kinase domains. No mutations were observed suggesting that this locus does not have a major influence on the ALS phenotype. However we can not rule out other genetic variation at the LRRK2 locus may play a role in parkinsonian disorders with amyotrophic lateral sclerosis and may be considered candidates for genetic screening.

PMID:
16865326
DOI:
10.1007/s00702-006-0525-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center